日本語English简体中文 繁體中文

4889 Renascience Inc.レナサイエンスTSE Growth / Pharmaceuticals

0 posts

Renascience Inc. (4889) at a glance

Code
4889
Company
Renascience Inc.
Local name
レナサイエンス
Market
TSE Growth
Sector
Pharmaceuticals
Share price
¥786 -48.0 (-5.76%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Renascience Inc. (4889) Stock Price HistoryNear a 52-week low

Renascience Inc. closed at ¥786 on Nov 20, 2026, −22.5% over 1 month, −59.5% over 1 year.

2026-11-11 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)¥1,021¥774Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥1,021Oct 21
1-Month Low¥774Nov 6
1-Week Change−12.3%vs Nov 13
1-Month Change−22.5%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥77,515 today (−22.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −22.5%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥786−48−5.76%
Nov 19 (Thu)¥834−4−0.48%
Nov 18 (Wed)¥838−9−1.06%
Nov 17 (Tue)¥847−28−3.20%
Nov 16 (Mon)¥875−21−2.34%
Nov 13 (Fri)¥896−3−0.33%
Nov 12 (Thu)¥899+6+0.67%
Nov 11 (Wed)¥893+36+4.20%
Nov 10 (Tue)¥857+55+6.86%
Nov 9 (Mon)¥802+28+3.62%
2026-11-11 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)¥1,368¥774Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥1,368Aug 20
3-Month Low¥774Nov 6
1-Month Change−22.5%vs Oct 20
3-Month Change−42.5%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥57,456 today (−42.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −42.5%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥786−48−5.76%
Nov 19 (Thu)¥834−4−0.48%
Nov 18 (Wed)¥838−9−1.06%
Nov 17 (Tue)¥847−28−3.20%
Nov 16 (Mon)¥875−21−2.34%
Nov 13 (Fri)¥896−3−0.33%
Nov 12 (Thu)¥899+6+0.67%
Nov 11 (Wed)¥893+36+4.20%
Nov 10 (Tue)¥857+55+6.86%
Nov 9 (Mon)¥802+28+3.62%
2026-11-11 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)¥1,745¥774May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥1,745Jun 9
6-Month Low¥774Nov 6
3-Month Change−42.5%vs Aug 20
6-Month Change−49.4%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥50,612 today (−49.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −49.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥786−19.1%
Oct 2026¥971−17.1%
Sep 2026¥1,171−10.3%
Aug 2026¥1,306−12.1%
Jul 2026¥1,485−4.7%
Jun 2026¥1,558+13.3%
May 2026¥1,375+17.2%
2026-11-11 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(非連結)¥2,220¥774Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥2,220Nov 28
52-Week Low¥774Nov 6
Year to Date−44.5%vs Dec 30
From 52-Week High−64.6%Nov 28

If you had invested ¥100,000 1 year ago, it would be worth ¥40,515 today (−59.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −59.5%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥786−19.1%
Oct 2026¥971−17.1%
Sep 2026¥1,171−10.3%
Aug 2026¥1,306−12.1%
Jul 2026¥1,485−4.7%
Jun 2026¥1,558+13.3%
May 2026¥1,375+17.2%
Apr 2026¥1,173−30.1%
Mar 2026¥1,678−13.8%
Feb 2026¥1,946+31.5%
Jan 2026¥1,480+4.5%
Dec 2025¥1,416−36.2%
Nov 2025¥2,220―
¥3,085¥276Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥3,085Aug 4, 2025
3-Year Low¥276Dec 16, 2024
Annualized Return+19.7%
Max Drawdown−74.9%

If you had invested ¥100,000 3 years ago, it would be worth ¥171,616 today (+71.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved +71.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥786−44.5%
2025¥1,416―
¥3,085¥276Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥3,085Aug 4, 2025
5-Year Low¥276Dec 16, 2024
Annualized Return−2.2%
Max Drawdown−74.9%

If you had invested ¥100,000 5 years ago, it would be worth ¥89,624 today (−10.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −10.4%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥786−44.5%
2025¥1,416―
¥3,085¥276Sep 20, 2021Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥3,085Aug 2025
All-Time Low¥276Dec 2024
Total Change−4.8%vs Sep 2021
Annualized Return−1.0%

If you had invested ¥100,000 in Sep 2021, it would be worth ¥95,157 today (−4.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +91.6%, while this stock moved −4.8%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥786−44.5%
2025¥1,416+376.8%
2024¥297−31.6%
2023¥434+18.3%
2022¥367−46.3%
2021¥683―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Sep 2021). Please check the latest prices before trading.

Renascience Inc. (4889) financial indicators

PBR
3.43
ROE
-17.38%
Dividend yield
0.00%

See all financial indicators for Renascience Inc. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of Renascience Inc. (4889)

Business overview

To solve problems in clinical practice, the company is developing a range of modalities, including drugs, medical devices and AI-based software as a medical device. Aiming to realize new medical care that lets people enjoy physical and mental health throughout their lives, it is working on treatments for diseases that affect healthy life expectancy, such as cancer, cardiovascular disease, respiratory disease and diabetes, as well as for diseases affecting women and children. It is also focusing on research in the longevity field, such as senolytic drugs that remove senescent cells. Its R&D began with the development of drugs such as PAI-1 inhibitors discovered through computer engineering and small-molecule screening.

Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.

Position within Pharmaceuticals (79 companies)

PBR3.43xAbove the sector median of 1.86x (No. 59 from the lowest)
ROE-17.38%No. 40 in the sector (highest first); median 4.17%
Market cap¥10.8 bnNo. 44 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥2,2202025/11/28
52-week low¥77411/6
Current position0.8%Where the low is 0% and the high is 100% (close on 11/20: ¥786)
Year to date-44.5%No. 64 of 77 in the sector (best first)
1 year-59.5%

Based on closing prices (adjusted for stock splits, excluding dividends).

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (4).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Renascience Inc. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English